// App-Quantinova.ai

AB0050 (2018) : Biomap® phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity

Researchers

Presenter

  • A. O’Mahony

Principal Investigators

  • E.L. Berg

  • H.E. Jones

  • B. Fitzpatrick

  • B. Hassett

  • S.M. Vicik

  • L. Marshall

  • K. Roshak

  • E. Choy

Medical Centers

  • Eurofins DiscoverX Corporation, South San Francisco

  • Pfizer, Collegeville

  • Pfizer Biotech, Dublin, Ireland

  • Pfizer Biotech, Andover, USA

  • Cardiff University School of Medicine, Cardiff, United Kingdom

Locations

  • United States

  • Ireland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Light Chain Bioscience - Novimmune SA

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved